To read more on this topic click here.
Parkinson’s gene therapy could improve motor symptoms
Author: Simge Eva DoganPublished: 14 November 2018
Prep: Cook: Serves:
UK researchers are trialling an innovative gene therapy that could improve motor symptoms – such as tremors and rigidity – experienced by people with Parkinson’s.
The therapy, named AXO-Lenti-PD, has been developed by biopharmaceutical companies Oxford BioMedica and Axovant Sciences.
The trial will work with 30 participants living with Parkinson’s at hospitals in London and Cambridge, UK and Paris, France. The first stage will evaluate the safety and dosage of the therapy – and the second stage will assess the long-term effects of the therapy on motor function.
For more information on Parkinson’s and gene therapy please visit Parkinson’s Europe website.
Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs
AI technology could diagnose Parkinson’s in less than three minutes
Share this story
#UniteForParkinsons around the world
The 2018 #UniteForParkinsons campaign reaches 8 millionREAD MORE
Women and Parkinson's
“Incompetence, racism and prejudice delayed my diagnosis”
Manon Day on being a young black woman with Parkinson’sREAD MORE
EU approval for Medtronic DBS systems improves access to full-body MRI scans
Patients receiving DBS therapy have the option of full-body MRI scansREAD MORE